Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
Status:
Completed
Trial end date:
2010-05-17
Target enrollment:
Participant gender:
Summary
This study will determine the effectiveness of an antidepressant in preventing or reducing
depressive symptoms in people with melanoma who are receiving Interleukin-2 (IL-2) treatment.